BRIEF published on 12/02/2025 at 07:05, 13 days 10 hours ago Aelis Farma launches a Phase 2B clinical trial for AEF0217 in people with Down syndrome Clinical Trial Aelis Farma CB1-SSi AEF0217 Down Syndrome
BRIEF published on 09/25/2025 at 22:20, 2 months 19 days ago Availability of the 2025 half-year financial report by Aelis Farma Financial Report Biopharmaceuticals Aelis Farma Medical Innovations CB1-SSi
PRESS RELEASE published on 09/25/2025 at 22:15, 2 months 19 days ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Aelis Farma announces availability of 2025 half-year financial report. Company specializes in CB1 receptor treatments for brain and peripheral diseases Financial Report Aelis Farma CB1 Receptor Brain Diseases Peripheral Diseases
BRIEF published on 07/31/2024 at 10:02, 1 year 4 months ago Aelis Farma successfully raises 4.5 million euros Euronext Paris Investors Fundraising Biopharmaceutical Aelis Farma
PRESS RELEASE published on 07/31/2024 at 09:57, 1 year 4 months ago Inside Information / Other news releases Aelis Farma successfully completes Reserved Offering, raising €4.5 million for drug development. CEO expresses gratitude to investors. New shares to be admitted for trading on Euronext Paris on Aug 2, 2024 Euronext Paris Capital Increase Drug Development Aelis Farma Reserved Offering
Published on 12/15/2025 at 16:35, 1 hour 17 minutes ago Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 2 hours 52 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 2 hours 52 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 3 hours 22 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 3 hours 52 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 17:45, 7 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 17:38, 14 minutes ago Stabilus SE approves share buyback program with a volume of up to €20 million
Published on 12/15/2025 at 17:36, 16 minutes ago EQS-Adhoc: Stabilus SE approves share buyback program
Published on 12/15/2025 at 17:15, 37 minutes ago His Highness Sheikh Mansour bin Zayed Al Nahyan Launches "Al Khail Square" at Abu Dhabi Equestrian Club
Published on 12/15/2025 at 17:45, 7 minutes ago ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:35, 17 minutes ago DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025
Published on 12/15/2025 at 11:50, 6 hours 2 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 23 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
